Arrowhead Pharmaceuticals

biopharmaceutical company
Organization public_company Q113530745
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 15 annual filings
Revenue
$829.45M
▲ 23258.2% YoY FY2025
Net Income
-$1.63M
▲ 99.7% YoY FY2025
Assets
$1.39B
▲ 21.5% YoY FY2025
EPS (diluted)
$-0.01
▲ 99.8% YoY FY2025
$0.00$228.10M$456.20M$684.29M$912.39M FY2011: $296.1K · NI -$3.13M (-1056.6% margin)FY2012: $146.9K · NI -$21.13M (-14383.6% margin)FY2013: $290.3K · NI -$31.14M (-10729.2% margin)FY2014: $175.0K · NI -$58.63M (-33503.0% margin)FY2015: $382.0K · NI -$91.94M (-24068.3% margin)FY2016: $158.3K · NI -$81.72M (-51614.6% margin)FY2017: $31.41M · NI -$34.38M (-109.5% margin)FY2018: $16.14M · NI -$54.45M (-337.3% margin)FY2019: $168.80M · NI $67.97M (40.3% margin)FY2020: $87.99M · NI -$84.55M (-96.1% margin)FY2021: $138.29M · NI -$140.85M (-101.9% margin)FY2022: $243.23M · NI -$176.06M (-72.4% margin)FY2023: $240.74M · NI -$205.28M (-85.3% margin)FY2024: $3.55M · NI -$599.49M (-16882.4% margin)FY2025: $829.45M · NI -$1.63M (-0.2% margin) '11'13'15'17'19'21'23'25
Revenue Net Income
Source: SEC EDGAR · latest 10-K filed 2025-09-30 · accession 0000879407-25-000029

Arrowhead Pharmaceuticals

Summary

Arrowhead Pharmaceuticals is a public company[1].

Key Facts

  • Arrowhead Pharmaceuticals's field of work was RNA interference[2].
  • Arrowhead Pharmaceuticals is in the country of United States[3].
  • Arrowhead Pharmaceuticals is in the country of US[4].
  • Arrowhead Pharmaceuticals's instance of is recorded as public company[5].
  • Arrowhead Pharmaceuticals's headquarters location is recorded as Pasadena[6].
  • Arrowhead Pharmaceuticals's stock exchange is recorded as Nasdaq[7].
  • Arrowhead Pharmaceuticals's industry is recorded as pharmaceutical industry[8].
  • 1989 marks the founding of Arrowhead Pharmaceuticals[9].
  • 2001-02-13 marks the founding of Arrowhead Pharmaceuticals[10].
  • Arrowhead Pharmaceuticals's official website is recorded as https://arrowheadpharma.com/[11].
  • Arrowhead Pharmaceuticals's legal form is recorded as Delaware corporation[12].
  • Arrowhead Pharmaceuticals's legal form is recorded as XTIQ[13].

Body

Founding

Recorded inception include 1989[9] and 2001-02-13[10].

Operations

Arrowhead Pharmaceuticals's headquarters location is recorded as Pasadena[6].

Industry

Arrowhead Pharmaceuticals's industry is recorded as pharmaceutical industry[8]. Its field of work was RNA interference[2].

Ownership

Arrowhead Pharmaceuticals's stock exchange is recorded as Nasdaq[7].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Arrowhead Pharmaceuticals. Retrieved May 5, 2026, from https://4ort.xyz/entity/arrowhead-pharmaceuticals
MLA “Arrowhead Pharmaceuticals.” 4ort.xyz Knowledge Graph, 4ort.xyz, 5 May. 2026, https://4ort.xyz/entity/arrowhead-pharmaceuticals.
BibTeX @misc{4ortxyz_arrowhead-pharmaceuticals_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Arrowhead Pharmaceuticals}}, year = {2026}, url = {https://4ort.xyz/entity/arrowhead-pharmaceuticals}, note = {Accessed: 2026-05-05}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Arrowhead Pharmaceuticals — https://4ort.xyz/entity/arrowhead-pharmaceuticals (retrieved 2026-05-05)

Canonical URL: https://4ort.xyz/entity/arrowhead-pharmaceuticals · Last refreshed: